创伤患者早期限制性氧疗与宽松氧疗:TRAUMOX2随机临床试验
TRAUMOX2多中心随机对照试验在丹麦、荷兰和瑞士的15个院前基地和5个主要创伤中心纳入直接转运、启动全创伤团队、预计住院至少24小时的成人创伤患者,随机1:1接受限制性氧疗(目标动脉血氧饱和度94%)或宽松氧疗(每分钟12-15 L氧气或吸入氧浓度0.6-1.0)8小时。30天内死亡和/或主要呼吸系统并发症在限制性氧疗组为16.1%(118/733),宽松氧疗组为16.7%(121/724),OR 1.01(95%CI 0.75-1.37),P=0.94,绝对差0.56个百分点(95%CI -2.70至3.82)。复合终点各组分无显著差异,不良事件和严重不良事件两组相似,但肺不张在限制性氧疗组较少见(27.6% vs 34.7%)。
要点
- 成人严重创伤患者院前或创伤中心入院时启动8小时限制性氧疗(目标SpO2 94%)与宽松氧疗(12-15 L/min或FiO2 0.6-1.0)相比,30天内死亡和/或主要呼吸系统并发症无显著差异(16.1% vs 16.7%,OR 1.01,95%CI 0.75-1.37,P=0.94)。
- 30天内死亡和主要呼吸系统并发症作为关键次要终点分别评估,两组间均无显著差异。
- 不良事件和严重不良事件两组相似,但肺不张在限制性氧疗组较少见(27.6% vs 34.7%)。
- 该试验在丹麦、荷兰和瑞士的15个院前基地和5个主要创伤中心进行,纳入直接转运、启动全创伤团队、预计住院至少24小时的成人创伤患者。
适用人群与场景
- 成人创伤患者,直接转运至医院并启动全创伤团队,预计住院至少24小时;纳入时间为2021年12月7日至2023年9月12日。
处置流程与药物剂量
- 限制性氧疗组:目标动脉血氧饱和度94%,持续8小时。
- 宽松氧疗组:每分钟12-15 L氧气或吸入氧浓度0.6-1.0,持续8小时。
- 干预在院前环境或创伤中心入院时启动。
研究设计与关键结果
- 多中心随机对照试验,在丹麦、荷兰和瑞士的15个院前基地和5个主要创伤中心进行,1979例随机,1508例完成试验;中位年龄50岁(IQR 31-65),73%男性,中位损伤严重度评分14(IQR 9-22)。
- 主要终点30天内死亡和/或主要呼吸系统并发症:限制性氧疗组118/733(16.1%),宽松氧疗组121/724(16.7%),OR 1.01(95%CI 0.75-1.37),P=0.94,绝对差0.56个百分点(95%CI -2.70至3.82)。
- 复合终点各组分(30天内死亡、主要呼吸系统并发症)两组间无显著差异。
- 不良事件和严重不良事件两组相似,但肺不张在限制性氧疗组较少见(27.6% vs 34.7%)。
证据类型、等级与局限
- 随机对照试验;原文未报告证据等级;局限:原文未报告局限性。
对床旁实践的改变
- 对于成人严重创伤患者,院前或创伤中心入院时启动8小时限制性氧疗(目标SpO2 94%)与宽松氧疗相比,未显著降低30天内死亡和/或主要呼吸系统并发症;限制性氧疗组肺不张发生率较低。
指南或共识出处
- ClinicalTrials.gov Identifier: NCT05146700。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Early administration of supplemental oxygen for all severely injured trauma patients is recommended, but liberal oxygen treatment has been associated with increased risk of death and respiratory complications.
OBJECTIVE: To determine whether an early 8-hour restrictive oxygen strategy compared with a liberal oxygen strategy in adult trauma patients would reduce death and/or major respiratory complications.
DESIGN, SETTING, AND PARTICIPANTS: This randomized controlled trial enrolled adult trauma patients transferred directly to hospitals, triggering a full trauma team activation with an anticipated hospital stay of a minimum of 24 hours from December 7, 2021, to September 12, 2023. This multicenter trial was conducted at 15 prehospital bases and 5 major trauma centers in Denmark, the Netherlands, and Switzerland. The 30-day follow-up period ended on October 12, 2023. The primary outcome was assessed by medical specialists in anesthesia and intensive care medicine blinded to the randomization.
INTERVENTIONS: In the prehospital setting or on trauma center admission, patients were randomly assigned 1:1 to a restrictive oxygen strategy (arterial oxygen saturation target of 94%) (n = 733) or liberal oxygen strategy (12-15 L of oxygen per minute or fraction of inspired oxygen of 0.6-1.0) (n = 724) for 8 hours.
MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of death and/or major respiratory complications within 30 days. The 2 key secondary outcomes, death and major respiratory complications within 30 days, were assessed individually.
RESULTS: Among 1979 randomized patients, 1508 completed the trial (median [IQR] age, 50 [31-65] years; 73% male; and median Injury Severity Score was 14 [9-22]). Death and/or major respiratory complications within 30 days occurred in 118 of 733 patients (16.1%) in the restrictive oxygen group and 121 of 724 patients (16.7%) in the liberal oxygen group (odds ratio, 1.01 [95% CI, 0.75 to 1.37]; P = .94; absolute difference, 0.56 percentage points [95% CI, -2.70 to 3.82]). No significant differences were found between groups for each component of the composite outcome. Adverse and serious adverse events were similar across groups, with the exception of atelectasis, which was less common in the restrictive oxygen group compared with the liberal oxygen group (27.6% vs 34.7%, respectively).
CONCLUSIONS AND RELEVANCE: In adult trauma patients, an early restrictive oxygen strategy compared with a liberal oxygen strategy initiated in the prehospital setting or on trauma center admission for 8 hours did not significantly reduce death and/or major respiratory complications within 30 days.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05146700.
参考来源
- Arleth T, Baekgaard J, Siersma V, et al. Early Restrictive vs Liberal Oxygen for Trauma Patients: The TRAUMOX2 Randomized Clinical Trial. JAMA. 2025. PMID: 39657224. doi:10.1001/jama.2024.25786
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。